News

Control-IQ+ Technology: How Does It Advance Automated Insulin Delivery for Type 2 Diabetes?

Tech Watch: The Latest in Diabetes Tech News

With so many things happening in the diabetes tech world, it can be hard to keep up. Stay up to date here with the latest diabetes tech news and alerts.

Diabetes Technology Highlights From ADA 2026

Here are some of the top technology highlights covered at the American Diabetes Association's 2026 scientific conference in New Orleans. 

Diabetes Technology: Choosing What’s Best for You

Key takeaways: * Continuous glucose monitors, insulin pumps, and automated insulin delivery systems help people with diabetes who use insulin spend more time in range. * Many people have been using wearable devices for years now, and there’s plenty of practical advice available for people just getting started. * Connected pens and inhaled insulin offer additional insulin delivery methods for people with diabetes looking for options beyond or in addition to pumps.

Join Trial Testing New Drug for Weight Management

A clinical trial is recruiting adults with type 2 diabetes to test a new long-lasting amylin drug for weight management.

Should You Microdose a GLP-1? Benefits and Risks

Key takeaways: * Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, including cost savings and minimizing side effects.  * Microdosing GLP-1 medications lacks clinical evidence, meaning doctors don’t have enough reliable data to confirm whether lower than approved doses are effective. * Compounded GLP-1 formulations, which may be used for microdosing, carry additional risks, including uncertain drug quality and imprecise dosing that may be especially dangerous for people who also take insulin.

Tzield (Teplizumab) to Delay Type 1 Diabetes

Tzield has been shown to delay the onset of type 1 diabetes by an average of two years. Here’s more about screening and whether treatment may be right for you.

Survodutide Shows Promising Weight Loss and Cardiometabolic Benefits

Survodutide is a new investigational dual GLP-1 injectable medication being tested for weight management in clinical trials.

Navigating Diabetes Stigma, Body Image, and Mental Health

What does diabetes stigma have to do with body image and your mental and behavioral well-being? Turns out, a whole lot. 

Diabetes Technology: Choosing What’s Best for You

Key takeaways: * Continuous glucose monitors, insulin pumps, and automated insulin delivery systems help people with diabetes who use insulin spend more time in range. * Many people have been using wearable devices for years now, and there’s plenty of practical advice available for people just getting started. * Connected pens and inhaled insulin offer additional insulin delivery methods for people with diabetes looking for options beyond or in addition to pumps.

Sending Your Child to Diabetes Camp

You Matter: Daniel Newman’s Call To Overcome Diabetes Distress and Stigma

Once consumed by diabetes burnout and kidney failure, diabetes advocate Dan Newman now runs marathons, challenges stigma, and helps others believe their lives are bigger than their diagnoses.

Planning for Pregnancy With Diabetes: Hope, Support, and Smart Tools

Key takeaways: * Most women with diabetes today can look forward to a healthy pregnancy, even though managing diabetes during this time takes extra effort and support. * The right team, early planning, and diabetes technology can make pregnancy safer and more manageable, no matter what type of diabetes. * Diabetes technology can ease some of the burden, but insurance gaps and limited access – especially for people with type 2 diabetes – remain a barrier.

Join Trial Testing Automated Insulin Delivery for Cystic Fibrosis-Related Diabetes

A clinical trial is recruiting teens and adults with cystic fibrosis-related diabetes to see if the iLet Bionic Pancreas AID system can help improve blood sugar management.

Medtronic MiniMed 780G: Overview, Features, and News

Key takeaways: * The Medtronic MiniMed 780G AID system automatically adjusts insulin doses from an insulin pump every five minutes based on CGM readings * Medtronic's Instinct, a CGM that uses Freestyle Libre technology, and a new CGM called the Simplera Sync [https://diatribe.org/diabetes-technology/medtronic-simplera-cgm-how-it-works-features-and-latest-updates] are now available in the US.   * In September, the FDA approved the MiniMed 780G for use in people with type 2 diabetes. 

Using GMI To Estimate Your A1C: How Accurate Is It?